Memorial Sloan Kettering Cancer Center Program

The Medical Genetics Residency Program at Memorial Sloan Kettering Cancer Center (MSK) in New York City is a comprehensive two-year training program designed to prepare physicians for a career in medical genetics. The residency is collaboratively offered alongside The NewYork-Presbyterian Hospital (NYPH) and is accredited by the ACGME, ensuring it meets the highest standards of graduate medical education.1

Both NYPH and MSK provide access to a waiting pool of diverse genetic cases, offering a unique learning experience in both the clinical and research settings. The residency aims to equip trainees with the skills necessary for the comprehensive diagnosis, management, and counseling of patients affected by genetic disorders or those at risk of inherited disorders.

Program Structure

The residency encompasses various clinical rotations, gaining experience in different specialty areas including:

• General genetics clinic
• Cancer predisposition clinic
• Craniofacial clinic
• Neurogenetics clinic
• Prenatal diagnosis clinic
• Preimplantation genetic diagnosis clinic
• Biochemical genetics clinics

Laboratory rotations focus on essential areas, including:

• Cytogenetics
• Biochemical genetics
• Molecular genetics

Through these diverse rotations, residents build a robust foundation in clinical genetics,1 facilitating exposure to a high volume of patients through MSK's Clinical Genetics Service which provides vital care for individuals with inherited cancer predispositions.

Research Opportunities

Research is a significant component of the residency, with both institutions focusing on relevant interests in medical genetics. At NYPH, key research interests pertain to syndrome recognition, clinical delineation, neurogenetics, and cancer predisposition.1 Meanwhile, MSK’s research endeavors center around four major domains:

• Oncogenesis
• Genetic susceptibility to cancer
• Animal models of human cancer
• Gene therapy techniques

This foundation in research provides residents with opportunities to engage in cutting-edge studies and contribute to advancements in the field.

Eligibility and Application

Eligible candidates for the Medical Genetics Residency include those with an MD or MD/PhD, who have completed at least one year of ACGME-accredited residency training in the United States or Canada.1 The program participates in the National Resident Matching Program (NRMP), with the application deadline set for July 30 and a program start date of July 1.

Prospective residents need to register for the MyERAS portal to begin the application process, ensuring they meet all necessary criteria including any specific requirements such as maximum failed STEP exams, and graduation timelines.

Visa Support

The Medical Genetics Residency Program supports visa sponsorship for international medical graduates. Typically, the program offers sponsorship for J-1 and H-1B visa types, allowing qualified international applicants to participate fully in the residency training without barriers related to immigration status.

Competitiveness

The residency program is known to be highly competitive. Candidates from diverse backgrounds including DO (Doctor of Osteopathy) and IMG (International Medical Graduate) are encouraged to apply, ensuring a bright mix of perspectives and experiences within the cohort. Applicants are advised to showcase a compelling portfolio of clinical experiences, research endeavors, and recommendations to enhance their competitiveness within the selection process.

Unique Aspects

This residency program distinguishes itself from others due to its affiliation with one of the premier cancer centers in the world, providing unparalleled access to leading-edge clinical practices and research opportunities for aspiring medical geneticists.1 Additionally, the collaborative nature between MSK and NYPH enriches the training experience, allowing residents to benefit from the expertise of specialists across various fields.